Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.
González-Martín A, Alba E, Ciruelos E, Cortés J, Llombart A, Lluch A, Andrés R, Álvarez I, Aramendía JM, de la Peña FA, Barnadas A, Batista N, Calvo L, Galve E, García-Palomo A, García-Sáenz JÁ, de la Haba J, López R, López-Vivanco G, Martínez-Jáñez N, de Dueñas EM, Plazaola A, Rodríguez-Lescure Á, Ruiz M, Sánchez-Rovira P, Santaballa A, Seguí MÁ, Tusquets I, Zamora P, Martín M. González-Martín A, et al. Among authors: aramendia jm. Curr Cancer Drug Targets. 2016;16(5):415-28. doi: 10.2174/1568009615666150817121731. Curr Cancer Drug Targets. 2016. PMID: 26278712 Review.
Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer.
Cortes J, Rodriguez J, Calvo E, Gurpide A, Garcia-Foncillas J, Salgado E, Aramendia JM, Lopez-Picazo JM, Hernandez B, Hidalgo R, Aristu JJ, Brugarolas A, Martin-Algarra S. Cortes J, et al. Among authors: aramendia jm. Am J Clin Oncol. 2004 Jun;27(3):299-303. doi: 10.1097/01.coc.0000071460.56153.f8. Am J Clin Oncol. 2004. PMID: 15170152 Clinical Trial.
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer.
Nieto Y, Aramendía JM, Espinós J, De la Cruz S, Fernández-Hidalgo O, Santisteban M, Arbea L, Aristu J, Martínez-Monge R, Moreno M, Pina L, Sola J, Zornoza G, Regueira FM. Nieto Y, et al. Among authors: aramendia jm. Cancer Chemother Pharmacol. 2010 Feb;65(3):457-65. doi: 10.1007/s00280-009-1049-y. Epub 2009 Jun 14. Cancer Chemother Pharmacol. 2010. PMID: 19526361 Free PMC article. Clinical Trial.
Breast-cancer adjuvant therapy with zoledronic acid.
Coleman RE, Marshall H, Cameron D, Dodwell D, Burkinshaw R, Keane M, Gil M, Houston SJ, Grieve RJ, Barrett-Lee PJ, Ritchie D, Pugh J, Gaunt C, Rea U, Peterson J, Davies C, Hiley V, Gregory W, Bell R; AZURE Investigators. Coleman RE, et al. N Engl J Med. 2011 Oct 13;365(15):1396-405. doi: 10.1056/NEJMoa1105195. Epub 2011 Sep 25. N Engl J Med. 2011. PMID: 21995387 Free article. Clinical Trial.
Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer.
Martínez-Fernández MI, Legaspi Folgueira J, Valtueña Peydró G, Cambeiro M, Espinós J, Aramendía JM, Minguez-Milio JA, Martínez-Monge R. Martínez-Fernández MI, et al. Among authors: aramendia jm. Int J Gynecol Cancer. 2016 Jul;26(6):1162-8. doi: 10.1097/IGC.0000000000000744. Int J Gynecol Cancer. 2016. PMID: 27327153 Clinical Trial.
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes.
Salas-Benito D, Conde E, Tamayo-Uria I, Mancheño U, Elizalde E, Garcia-Ros D, Aramendia JM, Muruzabal JC, Alcaide J, Guillen-Grima F, Minguez JA, Amores-Tirado J, Gonzalez-Martin A, Sarobe P, Lasarte JJ, Ponz-Sarvise M, De Andrea CE, Hervas-Stubbs S. Salas-Benito D, et al. Among authors: aramendia jm. Br J Cancer. 2021 Mar;124(6):1138-1149. doi: 10.1038/s41416-020-01218-4. Epub 2021 Jan 5. Br J Cancer. 2021. PMID: 33402737 Free PMC article.
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy.
de la Fuente A, Santisteban M, Lupón J, Aramendía JM, Díaz A, Santaballa A, Hernándiz A, Sepúlveda P, Cediel G, López B, Picazo JML, Mazo MM, Rábago G, Gavira JJ, García-Bolao I, Díez J, González A, Bayés-Genís A, Ravassa S. de la Fuente A, et al. Among authors: aramendia jm. Cancers (Basel). 2022 Jun 14;14(12):2941. doi: 10.3390/cancers14122941. Cancers (Basel). 2022. PMID: 35740602 Free PMC article.
42 results